BD Announces Results for Fourth Fiscal Quarter and...(-------- -------- --- ---...),Health

Date:11/4/2009

-------- -------- --- --- ---- TOTAL INTERNATIONAL $3,956,194 $3,958,254 (0.1) 7.4 (7.5) -------------- ---------- ---------- ---- --- ---- BECTON DICKINSON AND COMPANY SUPPLEMENTAL REVENUE INFORMATION REVENUES BY BUSINESS SEGMENTS AND UNITS Twelve Months Ended September 30, (continued) (Unaudited; Amounts in thousands) Total ------------------------------------------------- % Change -------------------------- FX FX 2009 2008 Reported Neutral Impact ---------- ---------- -------- ------ ------ BD MEDICAL ----------- Medical Surgical Systems $1,984,929 $2,004,854 (1.0) 4.5 (5.5) Diabetes Care 714,937 694,352 3.0 6.8 (3.8) Pharmaceutical Systems 952,443 942,136 1.1 7.4 (6.3) Ophthalmic Systems 78,537 78,693 (0.2) 5.3 (5.5) ------------- ------ ------ ---- --- ----- TOTAL $3,730,846 $3,720,035 0.3 5.7 (5.4) ----- ---------- ---------- --- --- ----- BD DIAGNOSTICS -------------- Preanalytical Systems $1,143,431 $1,123,528 1.8 6.4 (4.6) Diagnostic Systems 1,082,788 1,036,283 4.5 7.4 (2.9) ------------- --------- --------- --- --- ----- TOTAL $2,226,219 $2,159,811 3.1 6.8 (3.7) ----- ---------- ---------- ---
'/>"/>

SOURCE BD (Becton, Dickinson and Company) Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study